171 related articles for article (PubMed ID: 15585154)
1. [Clearance effect of different blood purification techniques on parathyroid hormone in renal function failure patients on maintenance hemodialysis].
Wang C; Lou TQ; Tang H; Chen ZJ; Yin PD; Yu XQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):753-5. PubMed ID: 15585154
[TBL] [Abstract][Full Text] [Related]
2. Hemofiltration or hemodiafiltration with on-line production of substitution fluid: clinical observation of safety and effectiveness.
Li X; Li M; Liu T; Li L; Duan L; Li Y; Yang G; Guo L
Chin Med J (Engl); 1997 Jul; 110(7):520-5. PubMed ID: 9594209
[TBL] [Abstract][Full Text] [Related]
3. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
4. Effect of blood purification on plasma levels of intact parathyroid hormone in patients with chronic renal failure.
Liu J; Liu ZQ; Tao HQ
Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):234-5. PubMed ID: 14965840
[TBL] [Abstract][Full Text] [Related]
5. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
8. [Vitamin B12 clearance (Kd-B12) in hemodialysis (HD) and hemodiafiltration (HDF)].
Casino FG; Mostacci SD; Santarsia G; Lopez T
G Ital Nefrol; 2004; 21 Suppl 30():S217-22. PubMed ID: 15750989
[TBL] [Abstract][Full Text] [Related]
9. Clinical aspects and applications of hemofiltration.
Weiss LG
Scand J Urol Nephrol Suppl; 1989; 118():1-64. PubMed ID: 2785286
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of serum leptin clearance with different blood purification].
Lou TQ; You YP; Chen ZJ; Shi CG; Liu X; Tang H
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Dec; 15(12):742-4. PubMed ID: 14659060
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
12. [Monitoring hemodialysis dose with ionic dialisance in on-line hemodiafiltration].
Maduell F; Puchades MJ; Navarro V; Torregrosa E; Rius A; Sánchez JJ
Nefrologia; 2005; 25(5):521-6. PubMed ID: 16392302
[TBL] [Abstract][Full Text] [Related]
13. Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis.
Flisiński M; Strózecki P; Stefańska A; Zarzycka-Lindner G; Brymora A; Manitius J
Kardiol Pol; 2007 Sep; 65(9):1068-75; discussion 1076-8. PubMed ID: 17975754
[TBL] [Abstract][Full Text] [Related]
14. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients.
Hwang JC; Chen CA; Wang CT; Chen HC
Ren Fail; 2008; 30(10):943-51. PubMed ID: 19016144
[TBL] [Abstract][Full Text] [Related]
16. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
17. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
[TBL] [Abstract][Full Text] [Related]
18. Effects of diabetes mellitus, age, and duration of dialysis on parathormone in chronic hemodialysis patients.
Nasri H; Kheiri S
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):608-13. PubMed ID: 18580021
[TBL] [Abstract][Full Text] [Related]
19. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
20. Pruritus and mast cell proliferation of the skin in end stage renal failure.
Matsumoto M; Ichimaru K; Horie A
Clin Nephrol; 1985 Jun; 23(6):285-8. PubMed ID: 4028525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
